Status:

UNKNOWN

Pathology Analysis of OPMD Patient Myotomies

Lead Sponsor:

Hillel Yaffe Medical Center

Conditions:

Oculopharyngeal Muscular Dystrophy

Eligibility:

All Genders

18-70 years

Brief Summary

The study aims to characterize the effect of OPMD mutation on muscle function. Muscle samples will be received from oculopharyngeal muscular dystrophy (OPMD) patients who undergo cricopharyngeal muscl...

Eligibility Criteria

Inclusion

  • OPMD patients both male and female.
  • OPMD patients between the ages 18-70 years.
  • OPMD patients who are referred to the cricopharyngeal muscle-cutting surgery as part of their usual treatment.

Exclusion

  • • OPMD patients not referred to the cricopharyngeal muscle-cutting surgery as part of their usual treatment.

Key Trial Info

Start Date :

March 19 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2023

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT03874910

Start Date

March 19 2019

End Date

March 1 2023

Last Update

March 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hillel Yaffe Medical Center

Hadera, Israel

Pathology Analysis of OPMD Patient Myotomies | DecenTrialz